Hematopoietic stem cell transplantation is associated with a severe immune deficiency. As a
result, the patient is at high risk of infections. Innate immunity, including epithelial barriers …

ALTHOUGH MANY ASPECTS of the development of malignant tumors are still incompletely
understood, conditions have been identified under which malignancies develop at a higher …

We report here the adoptive transfer, to patients with metastatic melanoma, of highly
selected tumor-reactive T cells directed against overexpressed self-derived differentiation …

Background In this study we tried to achieve successful transplantation in patients with acute
leukemia with the use of hematopoietic stem cells from donors who shared only one HLA …

We evaluated 18,014 patients who underwent allogeneic bone marrow transplantation
(BMT) at 235 centers worldwide to examine the incidence of and risk factors for …

We performed HLA-mismatched stem cell transplantation with megadoses of purified
positively selected mobilized peripheral blood CD34+ progenitor cells (PBPC) from related …

Autologous T cells targeting Epstein-Barr virus (EBV) latent membrane proteins (LMPs) have
shown safety and efficacy in the treatment of patients with type 2 latency EBV-associated …

Epstein‐Barr virus (EBV) is an ubiquitous herpesvirus which is carried as a latent infection of
B lymphocytes and salivary gland epithelial cells in over 90% of normal adults. Latently …

The landscape of therapeutic options for B cell malignancies has fundamentally changed
with regulatory and marketing approval of chimeric antigen receptor (CAR)-engineered T …

We retrospectively analyzed 55 patients given a fixed dose of rituximab (200 mg) on day+ 5
after an alternative donor transplant, to prevent EBV DNA-emia; 68 alternative transplants …